• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与新近感染的 HIV-1 控制者病毒复制控制和病毒学突破相关的因素。

Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.

机构信息

Department of Medicine, Center for AIDS Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Department of Medicine, University of Texas MD Anderson Cancer Center, Austin, TX, USA.

出版信息

EBioMedicine. 2017 Feb;16:141-149. doi: 10.1016/j.ebiom.2017.01.034. Epub 2017 Jan 26.

DOI:10.1016/j.ebiom.2017.01.034
PMID:28159573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5474502/
Abstract

HIV-1 controllers are patients who control HIV-1 viral replication without antiretroviral therapy. Control is achieved very early in the course of infection, but the mechanisms through which viral replication is restricted are not fully understood. We describe a patient who presented with acute HIV-1 infection and was found to have an HIV-1 RNA level of <100copies/mL. She did not have any known protective HLA alleles, but significant immune activation of CD8+ T cells and natural killer (NK) cells was present, and both cell types inhibited viral replication. Virus cultured from this patient replicated as well in vitro as virus isolated from her partner, a patient with AIDS who was the source of transmission. Virologic breakthrough occurred 9months after her initial presentation and was associated with an increase in CD4+ T cell activation levels and a significant decrease in NK cell inhibitory capacity. Remarkably, CD8+ T cell inhibitory capacity was preserved and there were no new escape mutations in targeted Gag epitopes. These findings suggest that fully replication-competent virus can be controlled in acute HIV-1 infection in some patients without protective HLA alleles and that NK cell responses may contribute to this early control of viral replication.

摘要

HIV-1 控制器是指在不接受抗逆转录病毒治疗的情况下控制 HIV-1 病毒复制的患者。这种控制在感染早期就已经实现,但限制病毒复制的机制尚未完全了解。我们描述了一位急性 HIV-1 感染患者,其 HIV-1 RNA 水平<100 拷贝/mL。她没有任何已知的保护性 HLA 等位基因,但存在显著的 CD8+T 细胞和自然杀伤(NK)细胞的免疫激活,这两种细胞类型都抑制了病毒复制。从该患者中培养的病毒与从她的伴侣(艾滋病患者,也是传播源)中分离出的病毒在体外具有相同的复制能力。病毒学突破发生在她初次出现后的 9 个月,与 CD4+T 细胞激活水平的增加和 NK 细胞抑制能力的显著下降有关。值得注意的是,CD8+T 细胞抑制能力得到了保留,并且在靶向 Gag 表位中没有新的逃逸突变。这些发现表明,在没有保护性 HLA 等位基因的情况下,完全复制能力的病毒可以在急性 HIV-1 感染中得到控制,并且 NK 细胞反应可能有助于这种早期的病毒复制控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/878c2adc6aa0/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/9bc012fdef9f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/d991f2ec74b3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/132e93839b73/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/c5b3686fc727/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/bad753e67fbc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/4a49d96594a6/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/80f246d890ac/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/878c2adc6aa0/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/9bc012fdef9f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/d991f2ec74b3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/132e93839b73/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/c5b3686fc727/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/bad753e67fbc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/4a49d96594a6/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/80f246d890ac/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f30f/5474502/878c2adc6aa0/gr8.jpg

相似文献

1
Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.与新近感染的 HIV-1 控制者病毒复制控制和病毒学突破相关的因素。
EBioMedicine. 2017 Feb;16:141-149. doi: 10.1016/j.ebiom.2017.01.034. Epub 2017 Jan 26.
2
CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.CD8 + T细胞广度和体外病毒抑制能力可区分有无保护性HLA I类等位基因的病毒血症控制者。
J Virol. 2016 Jul 11;90(15):6818-6831. doi: 10.1128/JVI.00276-16. Print 2016 Aug 1.
3
Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.聚合酶驱动的复制能力影响 HIV-1 型 C 亚型感染的疾病进展。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00811-18. Print 2018 Oct 1.
4
CD8 T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication.针对保守、交叉反应性 Gag 表位具有强大抑制 HIV-1 复制能力的 CD8 T 细胞。
Retrovirology. 2018 Jul 3;15(1):46. doi: 10.1186/s12977-018-0429-y.
5
Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.保护性杀伤细胞抑制受体/人类白细胞抗原基因型对 HIV-1 感染者中自然杀伤细胞和 T 细胞功能的影响。
AIDS. 2012 Sep 24;26(15):1869-78. doi: 10.1097/QAD.0b013e32835861b0.
6
Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers.针对 HIV Gag 蛋白的同种型转换免疫球蛋白 G 抗体可能为 HIV 控制器中的“保护性”人类白细胞抗原-B 等位基因提供替代或额外的免疫反应。
AIDS. 2013 Feb 20;27(4):519-28. doi: 10.1097/QAD.0b013e32835cb720.
7
Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.在早期HIV-1感染中,病毒控制的丧失在时间上与CD8 + T细胞反应的相继逃逸以及HIV-1特异性CD4 +和CD8 + T细胞频率的降低相关。
J Infect Dis. 2004 Aug 15;190(4):713-21. doi: 10.1086/422760. Epub 2004 Jul 20.
8
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.人类白细胞抗原I类分子限制的T细胞应答可能有助于控制人类免疫缺陷病毒感染,但这种应答对于长期病毒控制并非总是必要的。
J Virol. 2008 Jun;82(11):5398-407. doi: 10.1128/JVI.02176-07. Epub 2008 Mar 19.
9
Modelling Role of Protective and Nonprotective HLA Allele Inducing Different HIV Infection Outcomes.建立保护性和非保护性 HLA 等位基因对不同 HIV 感染结局影响的模型。
Bull Math Biol. 2024 Jul 13;86(9):107. doi: 10.1007/s11538-024-01334-9.
10
Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.自然杀伤细胞在一群精英抑制者中的作用:保护性KIR3DS1等位基因频率低且对1型人类免疫缺陷病毒体外复制的抑制作用有限。
J Virol. 2009 May;83(10):5028-34. doi: 10.1128/JVI.02551-08. Epub 2009 Feb 11.

引用本文的文献

1
Deep Thought on the HIV Cured Cases: Where Have We Been and What Lies Ahead?对艾滋病治愈病例的深度思考:我们走过了哪些历程,未来又将如何?
Biomolecules. 2025 Mar 5;15(3):378. doi: 10.3390/biom15030378.
2
IL-15-dependent immune crosstalk between natural killer cells and dendritic cells in HIV-1 elite controllers.HIV-1 精英控制者中自然杀伤细胞和树突状细胞之间依赖 IL-15 的免疫串扰。
Cell Rep. 2023 Dec 26;42(12):113530. doi: 10.1016/j.celrep.2023.113530. Epub 2023 Dec 3.
3
Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure.

本文引用的文献

1
Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation.HIV-1的长期自发控制与感染细胞的低频率和低效病毒再激活有关。
J Virol. 2016 Jun 10;90(13):6148-6158. doi: 10.1128/JVI.00419-16. Print 2016 Jul 1.
2
Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point.超急性HIV感染期间CD8 + T细胞活化的程度和动力学影响病毒载量设定值。
Immunity. 2015 Sep 15;43(3):591-604. doi: 10.1016/j.immuni.2015.08.012. Epub 2015 Sep 8.
3
Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study.
靶向 HIV 储存库:嵌合抗原受体治疗 HIV 治愈。
Chin Med J (Engl). 2023 Nov 20;136(22):2658-2667. doi: 10.1097/CM9.0000000000002904. Epub 2023 Nov 6.
4
Cohort-Specific Peptide Reagents Broaden Depth and Breadth Estimates of the CD8 T Cell Response to HIV-1 Gag Potential T Cell Epitopes.特定队列的肽试剂拓宽了对CD8 T细胞针对HIV-1 Gag潜在T细胞表位反应的深度和广度估计。
Vaccines (Basel). 2023 Feb 17;11(2):472. doi: 10.3390/vaccines11020472.
5
NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses.自然杀伤细胞、单核细胞和巨噬细胞在 HIV-1 控制中的作用:固有免疫反应的影响。
Front Immunol. 2022 May 27;13:883728. doi: 10.3389/fimmu.2022.883728. eCollection 2022.
6
The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity.新兴势力:HLA-C,病毒免疫中自然杀伤细胞的关键调节因子。
Cells. 2021 Nov 10;10(11):3108. doi: 10.3390/cells10113108.
7
Evolution of Serum Acute-Phase Glycoproteins Assessed by H-NMR in HIV Elite Controllers.HIV 精英控制者中通过 H-NMR 评估的血清急性期糖蛋白的演变。
Front Immunol. 2021 Sep 28;12:730691. doi: 10.3389/fimmu.2021.730691. eCollection 2021.
8
How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.精英控制者和治疗后控制者如何帮助我们寻找 HIV-1 治愈方法。
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI149414.
9
Combined Effects of HLA-B*57/5801 Elite Suppressor CD8+ T Cells and NK Cells on HIV-1 Replication.HLA-B*57/5801 优势抑制性 CD8+T 细胞和 NK 细胞对 HIV-1 复制的联合作用。
Front Cell Infect Microbiol. 2020 Mar 20;10:113. doi: 10.3389/fcimb.2020.00113. eCollection 2020.
10
Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial.罗米地辛对 BCN02 HIV-1 杀伤临床试验中 T 细胞激活、凋亡和功能的影响。
Front Immunol. 2020 Mar 20;11:418. doi: 10.3389/fimmu.2020.00418. eCollection 2020.
HIV 控制者的免疫和病毒学进展:ANRS CO21 CODEX 研究中病毒“波动”和免疫激活的作用
PLoS One. 2015 Jul 6;10(7):e0131922. doi: 10.1371/journal.pone.0131922. eCollection 2015.
4
CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types.CD8(+) T 细胞细胞毒性与人类免疫缺陷病毒-1 控制相关,可以通过各种表位和人类白细胞抗原类型介导。
EBioMedicine. 2014 Dec 22;2(1):46-58. doi: 10.1016/j.ebiom.2014.12.009. eCollection 2015 Jan.
5
Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis.在使用抗逆转录病毒暴露前预防药物期间感染艾滋病毒的女性中的抗体成熟情况。
J Infect Dis. 2015 Sep 1;212(5):754-9. doi: 10.1093/infdis/jiv110. Epub 2015 Feb 23.
6
Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.传播的病毒适应性和宿主T细胞反应共同决定了两名HIV-1感染者不同的感染结果。
PLoS Pathog. 2015 Jan 8;11(1):e1004565. doi: 10.1371/journal.ppat.1004565. eCollection 2015 Jan.
7
HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes.HIV的控制部分是由CD8 + T细胞对特定表位的靶向作用介导的。
J Virol. 2014 Nov;88(22):12937-48. doi: 10.1128/JVI.01004-14. Epub 2014 Aug 27.
8
Impaired Nef function is associated with early control of HIV-1 viremia.Nef功能受损与HIV-1病毒血症的早期控制相关。
J Virol. 2014 Sep 1;88(17):10200-13. doi: 10.1128/JVI.01334-14. Epub 2014 Jun 25.
9
Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.精英抑制性CD4+和CD8+ T细胞抑制HIV-1在单核细胞衍生巨噬细胞中复制能力的比较分析。
J Virol. 2014 Sep 1;88(17):9789-98. doi: 10.1128/JVI.00860-14. Epub 2014 Jun 18.
10
The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis.γ干扰素在HIV-1发病机制、治疗及预防中的意义
Front Immunol. 2014 Jan 13;4:498. doi: 10.3389/fimmu.2013.00498.